- Optimal 2:1 ratio EPA to DHA, provides convenient one-per-day dosing
- Clinical dosing of 1500 mg EPA and 750 mg DHA in triglyceride form, and 1000 IU vitamin D3 per teaspoon
- Pharmaceutical grade omega-3 blend, USP verified for quality and consistency
- Free of lipid peroxides and environmental pollutants, including heavy metals, pesticides, dioxins, PCBs, and other harmful compounds
- Sourced from wild anchovies, sardines, and/or mackerel, some of the best natural sources of EPA and DHA
- Harvested through sustainable fishing practices
- Comes in lemon flavour
On days when you don’t have time to steam broccoli or prepare a kale salad, you can still get important health benefits from cruciferous vegetables in CanPrev’s I-3-C 200. Phytonutrients in broccoli, kale, brussels sprouts, bok choy and cauliflower contain indole-3-carbinol (I-3-C), a strong antioxidant that not only repairs cells damaged by free radicals, but more importantly, has been shown to suppress the development of xenoestrogens, or “bad” estrogens.
Xenoestrogens are chemically-based, man-made estrogens that are found in everything from our food, drinking water, cleaning products and plastics to deodorants, pharmaceuticals and beyond. These imitation estrogens build up in fatty tissue in women and men and over time cause estrogen overload or estrogen dominance. The result? Xenoestrogens have been linked to the development of fibroids, tumours and cysts and many more serious diseases.
Selenium is a trace mineral that is a key player in several functions your body performs daily. The greatest concentrations are found in the thyroid gland. Selenium is a component of the enzyme that helps convert T4 to T3, producing the active form of thyroid hormone that your body needs.
Selenium also plays an important role in prostate health, helping to maintain healthy levels of Prostate-Specific Antigen (PSA) which is the marker for prostate cancer. Doctors like to see those levels nice and low. Canadian men are encouraged to have their PSA levels checked when they turn forty, the age when prostate cancer screening becomes imperative for most men.